Discovering early biomarkers of Alzheimer's disease using genetic and physics-informed networks

EPSRC · United Kingdom government procurement

GlobalGov surfaces government procurement from around the world, including the markets your competitors overlook.

January 31, 2028
Response Due
Active
Status

Opportunity Overview

Aims of the Project:
To derive novel biomarkers of Alzheimer's disease derived cortical diffusion and PET
To use these to constrain physics-informed models of disease progression
To compare against regional gene-expression through precision mapping to the Allen Brain Atlas
Summary:
Detecting early biomarkers of neurodegeneration is a highly challenging problem due to the complex organisational structure and high degree of variation of the human brain. Approximately 50% of dementia sufferers are thought to go undiagnosed in early stages. This limits treatment options and presents significant challenges for patient screening for clinical trials.

Recent studies have indicated that measures of cortical microstructure may present effective, non-invasive markers of early neurodegeneration [1,2]. However, so far these measures have been reported as summary measures averaged across the brain, when it is well known that cellular organisation varies significantly across the cortex, and that the presentation of dementia varies across individuals.

At the same time, recent work in mouse models has shown that the progression of tau pathology through the brain is extremely well constrained by neuronal connectivity, and that deviations from simple models of disease progression can be well explained by gene expression [3]. Similarly inspired models, trained on humans, have been constrained using positron emission tomography (PET) data from the Alzheimer's Disease Neuroimaging Iniative (ADNI) open dataset [4]. However, thus far these have been limited to global average models of brain organisation, not considering individual variability.

The goal of this project will therefore be to build precision models of the microstructural organisation of individual human brains [5-10], and to use these to constrain geometric deep learning [7, 11, 12] and biophysically-informed neural networks [4,13,14] models of Alzheimer's disease progression. Findings would be compared against gene...

This is one of 1,833 active United Kingdom Research Development opportunities most of your competitors will never see.

Your competitors are watching the same crowded contracts everyone else is. Track this opportunity and every one like it worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.

Start Free

Solicitation Details

Issuing agencyEPSRC
CountryUnited Kingdom
CategoryResearch Development
PublishedFebruary 01, 2024
Procurement stageActive solicitation
Response dueJanuary 31, 2028
StatusOpen — accepting responses
Official sourceView original notice
Last verifiedAugust 10, 2026

Source: UK Research and Innovation (UKRI) — Open Government Licence v3.0.

Related Opportunities in United Kingdom

Industrial Biotechnology Innovation Cluster
Conformations of musk odorants and their binding to human musk receptors
Advanced Device Concepts for Next-Generation Photovoltaics
Test FLARE (Test Flakiness Automated Reproduction and Explanation)
An interpretable AI framework for chemical retrosynthesis
Photochemical Carbonylation and Hydroformylation (funded by BASF)
Mechancial Engineering
Radiation Damage Studies in Silicon

See every United Kingdom Research Development opportunity your competition is missing. Free for 14 days.

Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required

See who is already competing here →

Get a free United Kingdom Research Development intelligence report in your inbox

A personalized report on United Kingdom Research Development opportunities, emailed in 5-10 minutes. One per month, no account needed.